Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,269 | 187 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $686.51 | 41 | $0 (2024) |
| ABBVIE INC. | $575.79 | 30 | $0 (2024) |
| GlaxoSmithKline, LLC. | $457.51 | 27 | $0 (2024) |
| Lilly USA, LLC | $239.70 | 15 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $217.44 | 14 | $0 (2024) |
| PFIZER INC. | $150.75 | 9 | $0 (2024) |
| Dexcom, Inc. | $117.41 | 7 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $92.04 | 5 | $0 (2024) |
| Amgen Inc. | $75.00 | 4 | $0 (2022) |
| Merck Sharp & Dohme LLC | $60.99 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $961.54 | 53 | Novo Nordisk Inc ($226.98) |
| 2023 | $1,118 | 68 | Novo Nordisk Inc ($335.15) |
| 2022 | $521.24 | 30 | Novo Nordisk Inc ($90.55) |
| 2021 | $668.79 | 36 | AbbVie Inc. ($228.37) |
All Payment Transactions
187 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.36 | General |
| Category: Cardiovascular | ||||||
| 11/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Diabetes Care | ||||||
| 11/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: PAIN | ||||||
| 11/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: VACCINE | ||||||
| 10/24/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/09/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Endocrinology | ||||||
| 10/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: VACCINES | ||||||
| 09/04/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: Oncology | ||||||
| 08/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: RESPIRATORY | ||||||
| 08/15/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Endocrinology | ||||||
| 08/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: Obesity | ||||||
| 08/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: ANTIBIOTIC | ||||||
| 07/27/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.89 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: VACCINES | ||||||
| 07/03/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: VACCINE | ||||||
| 06/26/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.66 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 483 | 673 | $62,908 | $36,793 |
| 2022 | 16 | 540 | 833 | $82,199 | $44,092 |
| 2021 | 12 | 402 | 616 | $52,683 | $30,126 |
| 2020 | 12 | 396 | 689 | $57,343 | $29,977 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 93 | 201 | $26,130 | $12,830 | 49.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 100 | 165 | $15,180 | $7,471 | 49.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 52 | 52 | $7,436 | $5,379 | 72.3% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 20 | 20 | $2,930 | $2,526 | 86.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 34 | 34 | $2,945 | $2,446 | 83.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $2,405 | $1,723 | 71.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 34 | 34 | $1,088 | $1,001 | 92.0% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 24 | 24 | $1,087 | $942.48 | 86.7% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 17 | 20 | $900.00 | $770.45 | 85.6% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 17 | 18 | $810.00 | $706.86 | 87.3% |
| 0134A | Adm sarscv2 bvl 50mcg/.5ml a | Office | 2023 | 11 | 11 | $495.00 | $431.97 | 87.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 26 | 34 | $510.00 | $295.12 | 57.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 21 | 22 | $792.00 | $184.00 | 23.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 21 | 25 | $200.00 | $85.25 | 42.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 90 | 202 | $26,260 | $13,965 | 53.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 100 | 150 | $13,800 | $7,062 | 51.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 51 | 51 | $7,293 | $5,528 | 75.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 21 | 135 | $8,568 | $5,358 | 62.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 47 | 49 | $4,025 | $3,280 | 81.5% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2022 | 26 | 26 | $6,500 | $2,093 | 32.2% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2022 | 26 | 26 | $5,200 | $1,470 | 28.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 48 | 50 | $1,600 | $1,388 | 86.7% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2022 | 19 | 19 | $4,750 | $1,020 | 21.5% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 21 | 21 | $945.00 | $785.82 | 83.2% |
| 0004A | Adm sarscov2 30mcg/0.3ml bst | Office | 2022 | 15 | 16 | $720.00 | $605.18 | 84.1% |
About Amy Potter
Amy Potter is a Nurse Practitioner healthcare provider based in Dover, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/23/2013. The National Provider Identifier (NPI) number assigned to this provider is 1144658469.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amy Potter has received a total of $3,269 in payments from pharmaceutical and medical device companies, with $961.54 received in 2024. These payments were reported across 187 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($3,269).
As a Medicare-enrolled provider, Potter has provided services to 1,821 Medicare beneficiaries, totaling 2,811 services with total Medicare billing of $140,986. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Dover, PA
- Active Since 10/23/2013
- Last Updated 10/23/2013
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1144658469
Products in Payments
- Rybelsus (Drug) $285.59
- Ozempic (Drug) $272.91
- SHINGRIX (Biological) $238.70
- MOUNJARO (Drug) $179.95
- UBRELVY (Drug) $178.16
- TRELEGY ELLIPTA (Drug) $176.97
- JARDIANCE (Drug) $165.40
- VRAYLAR (Drug) $161.33
- ELIQUIS (Drug) $145.88
- Dexcom G6 Transmitter (Medical Supply) $117.41
- XARELTO (Drug) $92.04
- SYNTHROID (Drug) $90.11
- QULIPTA (Drug) $86.14
- Wegovy (Drug) $82.16
- GARDASIL (Biological) $60.99
- XIFAXAN (Drug) $58.36
- Aimovig (Biological) $52.10
- STIOLTO RESPIMAT (Drug) $52.04
- NURTEC ODT (Drug) $47.72
- Cologuard Collection Kit (Device) $41.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Dover
Jessica Taylor, Aprn, APRN
Nurse Practitioner — Payments: $2,935
Courtney Coppola, Aprn, APRN
Nurse Practitioner — Payments: $2,669
Jane Tallent, A.n.p, A.N.P
Nurse Practitioner — Payments: $2,159
Suzette Flores, Np-C, NP-C
Nurse Practitioner — Payments: $2,030
Carlita Dobbie, Np, NP
Nurse Practitioner — Payments: $1,670
Patricia Acevedo, Np, NP
Nurse Practitioner — Payments: $1,668